Wednesday, July 8, 2026

pharma · Waldenstrom Macroglobulinemia · Non Small Cell Lung Cancer · CLRB

Cellectar Biosciences

Cellectar Biosciences clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

100 Campus Dr, 207, Florham Park, New Jersey 07932, US HQ
21 Employees
Public company Type
CLRB · NYSE Ticker
Company details
Status
Public
HQ
100 Campus Dr, 207, Florham Park, New Jersey 07932, US
Employees
21
Programs
17
Drugs
7
Patents
7
Intelligence · Clinical Programs

Cellectar Biosciences projects

1 ClinicalTrials.gov programs sponsored by Cellectar Biosciences.

Cellectar Biosciences has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Paclitaxel

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Cellectar Biosciences have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.